USC.edu
Are You a Patient?

Eunji Chung

Associate Professor of Biomedical Engineering

Image of Eunji Chung
Is this your profile? Click to edit
Phone +1 213 740 2925
Email eunchung@usc.edu
CTSI Profile

Publications

  • Genetically engineering cells to produce therapeutically boosted extracellular vesicles for cardiovascular calcification. Biomaterials. 2026 Feb; 325:123552.. View in PubMed
  • Therapeutic potential of urinary extracellular vesicles in delivering functional proteins and modulating gene expression for genetic kidney disease. Biomaterials. 2025 Oct; 321:123296.. View in PubMed
  • Clinically relevant dosing of miR-145 micelles curbs atherosclerosis in vivo. J Control Release. 2025 Aug 10; 384:113930.. View in PubMed
  • Endothelial-targeting miR-145 micelles restore barrier function and exhibit atheroprotective effects. Nanoscale Horiz. 2025 Apr 22; 10(5):976-986.. View in PubMed
  • Nanoparticles-based technologies for cholera detection and therapy. SLAS Technol. 2023 12; 28(6):384-392.. View in PubMed
  • In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease. SLAS Technol. 2023 08; 28(4):223-229.. View in PubMed
  • Strategies to deliver RNA by nanoparticles for therapeutic potential. Mol Aspects Med. 2022 02; 83:100991.. View in PubMed
  • Exosomes in Atherosclerosis, a Double-Edged Sword: Their Role in Disease Pathogenesis and Their Potential as Novel Therapeutics. AAPS J. 2021 07 26; 23(5):95.. View in PubMed
  • Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions. J Control Release. 2021 06 10; 334:127-137.. View in PubMed
  • miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype. Biomaterials. 2021 06; 273:120810.. View in PubMed
  • Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease. J Control Release. 2021 01 10; 329:1198-1209.. View in PubMed
  • CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation. J Control Release. 2021 01 10; 329:614-623.. View in PubMed
  • Targeting and therapeutic peptide-based strategies for polycystic kidney disease. Adv Drug Deliv Rev. 2020; 161-162:176-189.. View in PubMed
  • Hydroxyapatite-binding micelles for the detection of vascular calcification in atherosclerosis. J Mater Chem B. 2019 11 07; 7(41):6449-6457.. View in PubMed
  • Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis. J Nanobiotechnology. 2018 Nov 15; 16(1):92.. View in PubMed
  • Shape Effects of Peptide Amphiphile Micelles for Targeting Monocytes. Molecules. 2018 Oct 27; 23(11).. View in PubMed
  • Engineering Citric Acid-Based Porous Scaffolds for Bone Regeneration. Methods Mol Biol. 2018; 1758:1-10.. View in PubMed
  • Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis. J Vis Exp. 2017 11 17; (129).. View in PubMed
  • Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease. Biomater Sci. 2017 Jul 25; 5(8):1450-1459.. View in PubMed
  • Targeting and therapeutic peptides in nanomedicine for atherosclerosis. Exp Biol Med (Maywood). 2016 05; 241(9):891-8.. View in PubMed

Similar People